This is an AMP page which is for mobile devices.

View Non AMP page

Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AKBA - Akebia plummets as it abandons Vafseo for non-dialysis patients

AKBA - Akebia plummets as it abandons Vafseo for non-dialysis patients

October, 28 2025 05:45 PM Akebia Therapeutics Inc.

2025-10-28 17:45:05 ET

More on Akebia

Akebia Therapeutics, Inc. (AKBA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Akebia Therapeutics: Post-Earnings Dip Looks Like A Discounted Entry Ahead Of A Vafseo Inflection
Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript
Akebia outlines access to over 275,000 dialysis patients for Vafseo in Q4 as DaVita pilot launches
Akebia Q2 2025 Earnings Preview

For further details see:

Akebia plummets as it abandons Vafseo for non-dialysis patients

Stock Information

Company Name:	Akebia Therapeutics Inc.
Stock Symbol:	AKBA
Market:	NASDAQ
Website:	akebia.com

Get AKBA Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.